Advertisers Market your business with us! Join our Bird Flu Manual Online Automated Advertiser Program. To learn more click here. Existing members login here. Sponsor our eCourse Captive audience. Limited placements. First come first served. Click here for details. Make Money Do you run a website or blog? Do you participate in forums and discussion boards? Join our Bird Flu Manual Reseller Program. To learn more click here. Existing members login here.

Alpha Pro Tech N-95 Face Masks Check out our unbelievable prices! We ship worldwide. Alpha Pro N-95 Triosyn Face Masks Ideal for those who need to get close to the sick. Triosyn Masks for even greater protection Triosyn T-3000 Triosyn T-5000 Vira-Block Hand Anticeptic Clinically proven to be 15 times more effective than hand sanitizers. Vira Block NT-V2 Face Masks For the ultimate in pandemic flu Protection. NT-V2 Face Masks

Tamiflu for your staff and families Don’t rely on Government and hospital supplies. There won't be enough. Relenza - The Tamiflu alternative Evidence is emerging of Tamiflu resistent pandemic flu strains. Hedge your bets and get Relenza here. Business Preparedness Award winning ebook on how to minimize your losses against pandemic influenza. Bird Flu Books Our selection of the best books to help you prepare. Bird Flu Survival Guide A great for-the-home reference to own, just in case. Be prepared! Help For The Developing Pandemic Critical information you’ll need from this electronic book. Act Now, Survive An Emergency Later! What You Must Know To Prepare For A Disaster. Survival Kits Buying a Survival Kit? Read this run-down on what to look for. Video Conferencing An answer to Social Distancing? Read this review on the best equipment That’s available. Emergency Travel Kits Take a look at this selection from Amazon Alcohol Wipes Wipes should be in abundance around the office and made freely available for wiping surfaces frequently. Rubber Gloves Rubber gloves for cleaning and disinfecting suspect surfaces. Disinfecting Sprays Useful for cleaning and disinfecting surfaces and the surrounding air. Thermometers For measuring temperature of those at work and all persons entering the office. Surgical (Latex) Gloves Maintain a barrier between hands and any surfaces that may need to be touched. Organize For Safety Step by step guide for emergency and disaster preparedness.

Influenza Outbreak Simulator Educational and fun. Input your own parameters and see how it affects the spread. Warning: 20mb. Sickness Records Software Freeware for recording infection in the workplace Work Loss Calculator Estimate the potential number of work days lost. Bird Flu Screensaver Personal Hygiene Reminder screensaver. Bird Flu Response Template An exhaustive template to start off your preparedness. Bird Flu Certification Test Medical Professional? Take this certifcation test to see if you’re up to scratch. Swap Links with us Related website? Join our reciprocal links programme.

www.BIRDFLU-MANUAL.com
PANDEMIC PREPAREDNESS FOR BUSINESSES

Looking for the latest  Bird Flu News Stories?






Please note the sample Business Impact Analysis (BIA) shown in this section is designed for business continuity planning in general and is NOT specific to pandemic influenza preparedness. Of course the information gained by conducting a BIA using this example can be used for pandemic preparedness, and indeed should be used in the formation of your pandemic influenza plan.

The purpose of the Business Impact Analysis (BIA) is to identify the effect of many different external and internal impacts upon the various parts of your company in times of crisis. It will show which parts of the organisation will be most affected by an incident and what effect it will have upon the upline and downline operational processes as a whole.

A BIA is typically in the form of a questionnaire which is given to operational managers and/or departmental heads. They fill in the questionnaire themselves and are subsequently interviewed to clarify their answers.

Once all have been interviewed and the answers have been consolidated, the results will give tremendous insight into mission critical/non-critical processes, interdependent processes, back-ups, losses per day of disruption, and much more.

It is a very useful exercise to go through, especially for the respondents, who may have not analysed their jobs in such detail before, even if they have been in that position for many years.

You should use the BIA to establish which business functions/processes are the most critical to the company's survival, and equally, which functions/processes are least critical. It is important to note that the BIA is not a risk analysis or risk assessment. Risks are those 'smaller elements' which threaten processes, and are dealt with separately in our Risk Assessment section.

To see our Risk Assessment section, simply subscribe, then access it from the restricted Bird Flu Manual Online "Contents Page". Subscription is free.

The BIA will allow us to focus efforts on the risks to critical processes whilst allowing us to give less weighting (and human/financial resources) to risks which only effect non-critical processes.

The results of the BIA will ultimately form the backbone of a company's business continuity plan and is very important in the formation of the fundamental structure in which we will proceed. To this end, the questions need to be given due consideration when forming responses.

Additionally whenever possible, respondents should embed or attach charts/graphs/maps to further explain their departmental functions. As a minimum, they should include a freshly drawn department organisation chart and a process map of key processes. These will be identified in the questionnaire.

Respondents should answer the questions as best they can using as little or as much information as they feel is required. If in doubt, use a worst-case scenario to describe disruptions. They will have an opportunity at a later date to meet with the person carrying out the BIA in a one-on-one interview to discuss any questions they may have and to clarify their responses.

Please ensure they limit the scope of their responses to their department only. This will limit the possibility of 'double counting' the function/process ratings that are awarded later. Please note there are no right or wrong answers and no right or wrong way of completing this questionnaire, indeed many of the questions even call for 'gut feelings'.

To create your Business Impact Analysis Questionnaire use the sample generic questions below and add a few of your own as necessary to suit the idiosyncrasies of your industry type. Give respondents a 'box' after each question to place their answers in.

Sample Business Impact Analysis Questionnaire

(A ready made, fully customizable template of this document is available for purchase and download. For details please click here).

Note to respondents: Please read the whole questionnaire at least once before beginning your responses.


SECTION 1: RESPONDENT INFORMATION

1.1 Name: (Your name here:)

1.2 Job Title:

1.3 Department/Division:

1.4 Office Location: (building, floor, room number)

1.5 Experience: (How many years experience have you had with your company and in this industry in general?)

1.6 Skill Sets: (List additional skill sets and working experience you have acquired in your career)

1.7 Disruption Exposure: (Summarise your experiences of disruption in the workplace. What was the cause of the disruption? How long was it before a return to normal? What was the overall short term and long term impact to the business)

1.8 Cross Utilisation: (What other managerial and/or operational roles within your company have you held? Include on long and short term)

1.9 Pandemic Concerns: (If a global pandemic (such as Bird Flu) was to threaten your town/city, what would be your major concerns for your department from a business/operational perspective?)


SECTION 2: KEY DEPARTMENT FUNCTION

2.1 Key Departmental Function: (Describe in summary the primary function performed by your department)

2.2 Key Function Processes: (List and describe the processes used to accomplish this key function. Use process map graphics if possible)

2.3 Key Function Processes Cycle Times: (Quantify the cycle time for each key function process to complete in hours, days, weeks or months)

2.4 Key Function Processes Maximum Outage Tolerance: (List each key function process and state how long you can last without disruption if the process was to fail)

2.5 Key Function Processes Failure Impact Assessment: (List each key function process and give a rating on the operational impact from failure beyond the Maximum Outage Tolerance. Use: 0=no impact, 2=minimal, 4=moderate, 6=moderate heavy, 8=heavy, 10=severe)

2.6 Key Function Process Current Workaround: (List each key function process and state whether a workaround exists and what that workaround is)


SECTION 3: SECONDARY DEPARTMENT FUNCTION(S)

3.1 Secondary Functions: (describe in summary any secondary functions performed by your department)

3.2 Secondary Function Processes: (Describe the processes used to accomplish these secondary functions. Use process map graphics if possible)

3.3 Secondary Function Process Cycle Times: (Quantify the cycle time for each secondary ?function process to complete in hours, days, weeks or months)

3.4 Secondary Function Processes Maximum Outage Tolerance: (List each secondary function process and state how long you can last without disruption if the process was to fail)

3.5 Secondary Function Processes Failure Impact Assessment: (List each secondary function process and give a rating on the operational impact from failure beyond the Maximum Outage Tolerance. Use 0=no impact, 2=minimal, 4=moderate, 6=moderate heavy, 8=heavy, 10=severe)

3.6 Secondary Function Process Current Workaround: (List each secondary function process and state whether a workaround exists and what that workaround is)


SECTION 4: DEPARTMENTAL ASSIGNMENTS

4.1 Deliverables: (Describe the deliverables provided by your department)

4.2 Internal Clients: (List your internal clients)

4.3 External Clients: (List your external clients)

4.4 Compliance/Regulatory Issues: (Describe any regulatory requirements under which your department operates)

4.5 Peak Volumes/Critical Times: (What are your peak volume or critical times and why? Describe daily, weekly, monthly and/or annually)

4.6 Determining what?s lost: (Describe the process if any, you would use to determine what paper/electronic information was lost in any disaster)

4.7 Recovery/Recreation: (Describe the recovery/recreation process you would use for that information)

4.8 Handling Backlog: (Describe the process you would use to handle the backlog and catch up)

4.9 Short Term Planned Changes: (Describe any anticipated changes to the department structure or required systems over the next 24 months)


SECTION 5: INFORMATION TECHNOLOGY

5.1 Operating system used:

5.2 Computer applications used:

5.3 Mainframe/servers located:

5.4 Tech support provided by:

5.5 Manual Backup: (Should the systems be unavailable for an extended period, are there manual backup procedures in place? Are those procedures documented?)

5.6 Vital Records Backup: (Records - all media, hard and soft copies, that are considered essential to the continuation of your departmental services. List below all your current vital records including email and laptop usage)

Vital Data Records

Backed Up: Y or N

If Y - where

If N - action to be taken

How regular is back up performed


SECTION 6: INTER-DEPENDENCIES

6.1 Downline dependencies: (Describe who or what ? internally and externally - is dependent on your department?s function)

6.2 Downline dependencies location: (Where is work sent to from your department and how is it sent? List internal and external client names)

6.3 Downline dependencies failure: (List each downline dependency and describe the impact to each if you are not able to deliver)

6.4 Downline dependencies workaround: (List each downline dependency and describe any existing workarounds for you or the internal/external client)

6.5 Upline dependencies: (Describe who or what function ? internally and externally - your department is dependent on. Where and how is work received from to initiate processes?)

6.6 Upline dependencies failure: (List each upline dependency and describe the impact if any sources are not available?)

6.7 Upline dependencies workaround: (List each upline dependency and describe any existing workarounds)

6.8 Third Party Dependencies: (List any third party dependencies and the impact if they cannot deliver. eg. ad agency unable to provide copy, newswires services down, and describe any existing workarounds)


SECTION 7: DEPARTMENTAL PERSONNEL

7.1 Key Personnel (position) overall responsible for recovery:

7.2 Key Personnel (position) to lead the recovery:

7.3 Deputy Personnel (position) for primary and secondary key personnel:

7.4 Impact if no leadership available: (Describe what would happen if neither primary and secondary and deputies are not available)

7.5 Total Staff: (What is the total number of personnel in your department?)

7.6 Remote Working: (List job functions in your department which can be preformed off premises ie. at home. Include equipment/information requirements)

7.7 Staff Rotation: (Describe any staff rotation scheme or cross utilisation of job functions within your department)


SECTION 8: SUPPLIERS (includes vendors and support)

8.1 Critical Suppliers: (List your department?s critical suppliers, what is supplied and frequency of delivery)

8.2 Critical Supplier Failure: (What is the impact if supply is not available. State maximum tolerances where possible)

8.3 Critical Supplier Failure Workaround: (What workarounds are in place if supply is not available? State maximum tolerances where possible)

8.4 Critical Supplier Contingency Plan: (List suppliers and state if they have a documented contingency plan. Do you have a copy? Has it been tested?)

8.5 Critical Supplier Obligations (State what contractual obligations exist for supply continuity)


SECTION 9: ALTERNATE SITES

9.1 Primary: (Name your primary alternate site location. Include address, space availability, description of infrastructure, communications/ IT access)

9.2 Primary Site Logistics and Special Needs: (Describe physical requirements including security, proximity to upline/downline units, restrictions, access, transport to/from. What set up time is required?)

9.3 Secondary: (Name your secondary alternate site location. Include address, space availability, description of infrastructure, communications/ IT access)

9.4 Secondary Site Logistics and Special Needs: (Describe physical requirements including security, proximity to upline/downline units, restrictions, access, transport to/from. What set up time is required?)


SECTION 10: DEPARTMENT REVENUES & EXPENSES

10.1 Revenues: (List the primary and secondary departmental functions and estimate annual revenues for each one. Put 'nil' if function is not revenue generating)

10.2 Revenues Recapture: (State as a percentage the likelihood of recapturing revenue lost to disruption if the disruption lasts 1 day, 2 days, 3 days etc.)

10.3 Recurring Contractual Revenues: (As a percentage of total departmental revenues what percentage comes from long term recurrent contracts and what comes from daily or short term contracts)

10.4 Material Departmental Costs: (List the Top 5 largest departmental costs eg. staff costs, rental, raw material, paper etc.)

10.5 Mitigating Savings: (What dollar savings would be made in the event of a disruption? Eg. reduction in overtime, or 'rent free period' during building closure. Show the impact if the disruption lasts 1 day, 2 days, 3 days etc.)


SECTION 11: EXPOSURE IDENTIFICATION MATRIX

11.1 Using the accumulated data you have attained by completing the previous sections in this questionnaire, please show your overall 'feel' by populating the following matrix. Determine the exposure that would be incurred by your department should an unplanned interruption in operations occur. In order to establish financial impact, we must estimate loss associated with the loss of the facility and/or automation.

To assist with loss identification, the following impact categories apply:


The following number scores have been established to provide firm tangible and intangible exposure categories for cross-company comparison:

Cumulative Dollar-Loss Ranges (Tangible)

Customer Service and Goodwill Loss Ranges (Intangible)

Using the Impact Categories to classify the type of loss incurred and the Loss Ranges (0 through 10), specify your estimated amount of exposure during each time period below:


Example:

We encourage you to compile your own Business Impact Analysis Questionnaire and use it to analyse the processes within your business.

You are welcome to make use of (for your own use only) the questions from the example BIA we have provided for you above. These are generic questions which work for almost all businesses, however you may wish to customize the questions to suit your own needs.

Alternatively, download our ready made, fully customizable, Business Impact Analysis Questionnaire Template at our special 50% discount price of only US$24.95 (comes in MS. Word format with a PDF copy).

This discounted price won't last long so we encourage you to take advantage of this offer now.


The 16 page template includes the following Sections:

Introduction and Instructions
Section 1: Respondent Information
Section 2: Key Department Function
Section 3: Secondary Department Function(s)
Section 4: Departmental Assignments
Section 5: Information Technology
Section 6: Inter-Dependencies
Section 7: Departmental Personnel
Section 8: Suppliers (Includes vendors and support)
Section 9: Alternate Sites
Section 10: Department Revenues & Expenses
Section 11: Exposure Identification Matrix

To purchase the template now (even if it's the middle of the night), simply click on the secure PayPal payment button below.

(Please note: Payment will be made to our parent company 'Continuity Business Solutions Ltd.')


Once you have made your payment by credit card or your PayPal account if you have one, you will immediately receive an email with a link to our download page where you can download the template directly to your desktop.

It’s that easy! You’ll be working on your Business Impact Analysis Questionnaire in just a few minutes.


While you’re there check out some of our other great time saving pandemic preparedness products. And don't forget, all of our products come with a 30-day no questions asked money back guarantee!

---

For all the tutorials, templates and tools you’ll need to prepare your business for pandemic flu, including conducting your own business impact analysis check out the Pandemic Response Manual for Business Preparedness and Survival.

|





More help? Need a complete solution? Something with all the hard work done for you? Something with customisable templates of procedures, presentations, project timelines and tutorials … to hand hold you through it all? Then you’re looking for our Pandemic Response Manual. It has all of this and much, much more. To learn more about it and get some free stuff click here.





|

(Our Manual gets reviewed and updated regularly so make sure you add this page to your favorites and come back often!)

Bird Flu Articles  Bird Flu Books  Bird Flu Directory  Link Partners  Importance of Planning  Public Health Sector Actions  Avian Flu Information  Hygiene Awareness Posters  Bird Flu - a Basic Understanding  Bird Flu Characteristics  Bird Flu FAQ  Bird Flu Information  Bird Flu Pictures  Bird Flu Summary Tips  Bird Flu Symptoms  Bird Flu Videos  Bird Flu vs Regular Disruption  Communications Management  Communications Tree  Pandemic Activations Phases  Pandemic Response Phases  Risk Assessment - Intro  Risk Analysis People  Risk Analysis Process  Risk Analysis Suppliers  Risk Analysis Utilities  Customer Confidence  Pandemics Through History  Business Impact Analysis - Intro  Business Impact Analysis Questionnaire  Emergency Callout Tree  Influenza Screening Flowchart  Customer Management  Flu Mortality Index  Face Masks  Pandemic vs Seasonal Flu Differences

Pandemic Flu  Flu vs. Cold Differences  Influenza Manager  Lists and Forms  Managing Illness at Work  Office Access Control - Intro  Office Access Controls - Orange  Office Access Controls - Red  Office Access Controls - Yellow  Sterile Office Environment  Pandemic Flu Information  Pandemic Influenza FAQ  Personal Hygiene Education  Promoting Staff Awareness  Drills and Practice  Public Health Sector  Quarantine Room  Regulatory Compliance  Report of Recommendations  Sample Project Timeline  Sickness Response Procedures  Sickness Contact Tracking  Social Distancing  Staff Training  Pandemic Stockpiling  Supply Shortages  Travel Application Form  Travel Policy Guidelines - Intro  Travel Policy Guidelines - Orange  Travel Policy Guidelines - Red  Travel Policy Guidelines - Yellow  Understanding Bird Flu  Workforce Management  Workplace Disinfection  Hand Antiseptic

More help? Need a complete solution? Something with all the hard work done for you? Something with customisable templates of procedures, presentations, project timelines and tutorials … to hand hold you through it all? Then you’re looking for our Pandemic Response Manual. It has all of this and much, much more. To learn more about it and get some free stuff click here.

Latest Health News and Medical News posted throughout the day, every day.

01/20/2010 09:00 PM

1918 And 2009 H1N1 Flu Probably Not Spread By Birds

The two strains of the H1N1 influenza virus responsible for the 1918 and 2009 global flu pandemics do not cause disease in birds. The results of the study, published in the February issue of the Journal of General Virology, also show it is unlikely that birds played a role in the spread of the H1N1 virus in these pandemics...

01/14/2010 05:00 PM

New Research Findings Can Improve Avian Flu Surveillance Programs

Genetic analyses of avian influenza in wild birds can help pinpoint likely carrier species and geographic hot spots where Eurasian viruses would be most likely to enter North America, according to new U.S. Geological Survey research...

01/08/2010 06:00 PM

NexBio Initiates Phase II Trial Of DAS181 (Fludase(R)) For Treatment Of Influenza, Including Pandemic Influenza A(H1N1)

NexBio, Inc. announced the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection. DAS181 is an investigational host-targeted drug candidate that blocks entry of influenza virus into cells of the respiratory tract...

01/07/2010 08:00 PM

Also In Global Health News: ART Access In Zimbabwe; Indonesia Bird Flu Deaths; Kenya Floods; Solomon Island Tsunami

Zimbabwe Wants To Boost Access To ART By End Of 2010, Health Minister Says Zimbabwe's government plans work with international organizations to increase the number of people receiving anti-retroviral therapy (ART) to 300,000 by the end of the year, up from the 180,000 who currently get the drugs, Henry Madzorera, the country's health minister, said on Tues...

12/25/2009 04:00 PM

Compound Found To Safely Counter Deadly Bird Flu

The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public-health officials awake at night. Now, however, a study published this week (Dec...

12/22/2009 06:00 PM

Compound Found To Safely Counter Deadly Bird Flu

The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public health officials awake at night. Now, however, a study published this week (Dec...

12/22/2009 05:00 PM

Medicago Reports Positive Phase I Results For Its Avian Flu Pandemic Vaccine

Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine")...

12/07/2009 06:00 PM

'Rational Drug Design' Identifies Fragments Of FDA-Approved Drugs Relevant To Emerging Viruses

A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies -- according to a present...

12/04/2009 07:00 PM

Transplant Infectious Disease Experts Provide Pandemic Guidance

Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic...

11/17/2009 04:00 PM

Scientists Put Interactive Flu Tracking At Public's Fingertips

New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say...

11/02/2009 04:00 PM

Potential Downside Of Yearly Influenza Vaccination For Children

An article published Online First and in the December edition of The Lancet Infectious Diseases discusses the benefits and disadvantages of vaccination for children against seasonal flu. It reports that infection with "seasonal" influenza A could in fact benefit children by giving them improved immunity against pandemic strains such as the current swine flu H1N1 strain...

10/26/2009 07:00 PM

News From The Journals Of The American Society For Microbiology

Genes May Determine Susceptibility to H5N1 Avian Influenza A Virus Infection A new study found genetic variations in mice affect their susceptibility to and severity of H5N1 avian influenza A virus infection suggesting that humans who contract the virus may be genetically predisposed. The researchers from St...

10/22/2009 04:00 PM

Rice, UT-Austin Team Wins Stimulus Funds To Study Influenza A

Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu...

10/15/2009 09:00 PM

Previous Flu Viruses Provided Some Immunity To Current Swine Flu, Study Shows

University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years...

10/14/2009 05:00 PM

ImmuneRegen BioSciences(R) Initiates Homspera(R) Studies Against Global Influenza Threat

ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist...

10/09/2009 05:00 PM

Protecting Humans And Animals From Diseases In Wildlife

Avian influenza (H5N1), rabies, plague, Bovine Spongiform Encephalopathy (BSE), and more recently swine flu (H1N1) are all examples of diseases that have made the leap from animals to humans...

10/06/2009 09:00 PM

News From Annals Of Internal Medicine, October 6, 2009

Early Releases: 1. Earlier H1N1 Vaccination Prevents More Deaths, Saves Health Care Costs A vaccine for H1N1 influenza is anticipated to become available this fall. With the amount and timing of vaccine release still in question, policy makers struggle to set priorities regarding who should be vaccinated when...

10/02/2009 06:00 PM

Medicago Begins Human Clinical Testing With Its Avian Flu Pandemic Vaccine

Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has initiated a Phase I human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrolment is ongoing and vaccination has commenced...

08/28/2009 07:00 PM

H1N1 Flu In Turkeys May Spread

The detection of an H1N1 virus in turkeys in Chile raises concern that poultry farms elsewhere in the world could also become infected with the pandemic flu virus currently circulating in humans, FAO said today. Chilean authorities reported on 20 August that the pandemic H1N1/2009 virus was present in turkeys in two farms near the seaport of Valparaiso, Chile...

08/28/2009 06:00 PM

Lakewood-Amedex Inc. To Develop Broad Spectrum Influenza Drug To Include H1N1 And H5N1 Type A Strains

Lakewood-Amedex Inc...

Add this page to your favorite social networking website: